{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Updated: Eli Lilly & Company, confronted with research setbacks and pending patent losses, reported a quarterly profit on Thursday that beat Wall Street estimates.", "headline": {"main": "Lilly's Earnings Beat Expectations", "kicker": "Prescriptions"}, "abstract": "The company has experienced a series of research setbacks.", "print_page": null, "word_count": 716, "_id": "4fd39d808eb7c8105d8defa6", "snippet": "The company has experienced a series of research setbacks.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://prescriptions.blogs.nytimes.com/2010/10/21/lillys-earnings-beat-expectations/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Duff", "lastname": "WILSON"}], "original": "By DUFF WILSON"}, "document_type": "blogpost", "pub_date": "2010-10-21T13:21:25Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Insurers are urging doctors to use standard treatments instead of individualized, unproven courses of therapy.", "headline": {"seo": "Health Insurers Test New Payment Incentives for Cancer Care", "main": "Insurers Test New Cancer Pay Systems", "print_headline": "Insurers Test New Cancer Pay Systems"}, "abstract": null, "print_page": "1", "word_count": "1237", "_id": "541bd7627988100a1c660614", "snippet": "Insurers are urging doctors to use standard treatments instead of individualized, unproven courses of therapy.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/20/health/policy/20cancer.html", "multimedia": [{"subtype": "xlarge", "url": "images/2010/10/20/business/CANCER-1/CANCER-1-articleLarge.jpg", "height": 315, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2010/10/20/business/CANCER-1/CANCER-1-articleLarge.jpg", "xlargeheight": "315"}, "type": "image"}], "subsection_name": "Money & Policy", "keywords": [{"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Doctors", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "United Healthcare Insurance Co", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Aetna Incorporated", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Wellpoint Inc", "is_major": "N", "rank": "8", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Reed", "lastname": "ABELSON"}], "original": "By REED ABELSON"}, "document_type": "article", "pub_date": "2010-10-20T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Hormone replacement therapy after menopause, which increases breast cancer risk, also makes the cancer worse.", "headline": {"seo": "Prempro Hormone Therapy Amplifies Breast Cancer Risks, Study Finds", "main": "Breast Cancer Seen as Riskier With Hormone", "print_headline": "Breast Cancer Seen as Riskier With Hormone"}, "abstract": null, "print_page": "1", "word_count": "1115", "_id": "541bd4927988100a1c6605d0", "snippet": "Hormone replacement therapy after menopause, which increases breast cancer risk, also makes the cancer worse.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/20/health/20hormone.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Hormones", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Breasts", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Denise", "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "2010-10-20T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "If you are taking a prescription medicine and you are older than 60, it is probably a cholesterol-lowering drug. If you are 20 to 59, it is more likely to be an antidepressant.", "headline": {"seo": "Prescription Drug Use Soars in U.S.", "main": "Prescription Drug Use Soared in Past Decade", "kicker": "Vital Statistics", "print_headline": "Prescription Drug Use Soared in Past Decade", "content_kicker": "Vital Statistics"}, "abstract": null, "print_page": "7", "word_count": "375", "_id": "541bc82c7988100a1c6604c1", "snippet": "If you are taking a prescription medicine and you are older than 60, it is probably a cholesterol-lowering drug. If you are 20 to 59, it is more likely to be an antidepressant.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2010/10/19/health/research/19stats.html", "multimedia": [], "subsection_name": "Research", "keywords": [{"rank": "1", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Elderly", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2010-10-19T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 4, "offset": 0, "time": 38}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}